Previous Close | 0.8601 |
Open | 0.8726 |
Bid | 0.8672 x 400 |
Ask | 0.8766 x 200 |
Day's Range | 0.8610 - 0.8798 |
52 Week Range | 0.6500 - 1.4900 |
Volume | |
Avg. Volume | 1,602,990 |
Market Cap | 351.146M |
Beta (5Y Monthly) | 2.01 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Amarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight more years. It achieves success in defending another patent on the drug against third parties.
Amarin ( NASDAQ:AMRN ) Full Year 2023 Results Key Financial Results Revenue: US$306.9m (down 17% from FY 2022). Net...
It's been a sad week for Amarin Corporation plc ( NASDAQ:AMRN ), who've watched their investment drop 11% to US$1.06 in...